Single‐Dose Pharmacokinetics of the CCR9 Receptor Antagonist Vercirnon in Healthy US and Japanese Subjects

Publisher: John Wiley & Sons Inc

E-ISSN: 2160-7648|2|4|387-393

ISSN: 2160-763X

Source: Clinical Pharmacology In Drug Development, Vol.2, Iss.4, 2013-10, pp. : 387-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract